相关实验视频

Updated: Jan 9, 2026

Purification of Extracellular Trypanosomes, Including African, from Blood by Anion-Exchangers Diethylaminoethyl-cellulose Columns

Purification of Extracellular Trypanosomes, Including African, from Blood by Anion-Exchangers Diethylaminoethyl-cellulose Columns

Published on: April 6, 2019

试蓝溶液的比较纯度:杂质概况及其临床影响

Richard Packard¹

¹Emeritus consultant surgeon Prince Charles Eye Unit Windsor UK.

Journal of cataract and refractive surgery

|December 11, 2025

概括

对于高度试蓝眼科溶液的担忧是毫无根据的. 纯度,而不是度,是关键,杂质如单化合物带来风险. 高纯度产品没有显示有毒前段综合征的发生.

科学领域:

眼科医生眼科眼科
手术创新在外科创新.
眼科药物安全性眼科药物安全性

背景情况:

最近的出版物质疑0.4%的青眼科溶液的安全性,因为度更高.
关于潜在的毒性,出现了理论上的担忧,需要进一步调查染料的安全性.

研究的目的:

为了研究高度青眼科溶液的安全性.
为了区分染料度和杂质水平作为潜在毒性的因素.
评估杂质的临床影响,特别是单化合物.

主要方法:

对青度和杂质的现有证据的审查.
分析各种试蓝产品中的染料度,剂量和杂质含量.
高性能液态色谱 (HPLC) 用于确定纯度和量化单化合物.

主要成果:

试蓝眼科溶液的主要问题是杂质的含量,而不是染料度.
制造用于人类使用的产品,如CAPSULBlue,VisionBlue和MembraneBlue,其纯度明显更高.
CAPSULBlue显示出异常低的,几乎不存在的,单化合物水平.

结论:

蓝眼科溶液的安全性与纯度有关,特别是没有有害杂质,如单化合物.
设计用于眼科手术的高纯度试蓝配方与缺乏报告的有毒前段综合征有关.
通过使用严格控制的杂质配置文件的试蓝产品,提高了临床安全性.

更多相关视频

In Vitro Drug Screening Against All Life Cycle Stages of Trypanosoma cruzi Using Parasites Expressing β-galactosidase

In Vitro Drug Screening Against All Life Cycle Stages of Trypanosoma cruzi Using Parasites Expressing β-galactosidase

Published on: November 5, 2021

Bioluminescence Imaging to Detect Late Stage Infection of African Trypanosomiasis

Bioluminescence Imaging to Detect Late Stage Infection of African Trypanosomiasis

Published on: May 18, 2016

相关概念视频

Pharmaceutical Alternatives: Excipients and Impurities-Related Therapeutic Nonequivalence

Pharmaceutical Alternatives: Excipients and Impurities-Related Therapeutic Nonequivalence

Pharmaceutical products contain more than just the active drug; they also contain various excipients such as binders, solubilizers, stabilizers, preservatives, and other elements. In some cases, impurities or contaminants might be present. Traditionally, quality control in pharmaceuticals has primarily focused on the analysis of the active drug, often overlooking the impact of these additional components. The recent issue with heparin contamination by over-sulfated chondroitin sulfate, a...